Siu-Fun Wong, PharmD

Research & Grantsmanship 

  Funded Research Project (PI)

• S1013 A Phase II Prospective Study of Epidermal Growth Factor Receptor (Her-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy – EGFRI 18 (FACT-EGFRI 18) Questionnaire for EGFRI-induced skin toxicities.                 Wong SF (Study Chairman), C Moinpour, J Wade, K Humpries,  J Unger , M Lacouture, L Wagner,                 Sponsor: Southwest Oncology Group/ Division of Cancer Prevention, NCI – Activated 11/13/2011 ( 10/2011 )

  Non-Funded Research Project

• Retrospective Comparative Evaluation of Epidermal Growth Factor Receptor Inhibitors-induced dermatologic toxicities between Japan and United States: Is there a Difference? Wong SF, Protocol Chair and Principal Investigator (USA), Etsuko UEJIMA, PhD, Principal Investigator (Osaka University, Japan) USA Investigators: Loma Linda University: Hamid Mirshahidi, MD, Jefmar Dickey, PY4; Erica Yunson Lee, PY3. Memorial Sloan Kettering Cancer Center: Mario Lacouture, MD; Nelly G. Adel, PharmD, BCOP, BCPS VA San Diego Medical Center: Timothy Chen, PharmD; Muoi Gi, PharmD; Mark Bounthavong, PharmD Osaka University, Japan Investigators: Sari Nakagawa, M. Pharm, Yoshiaki Okamoto, B. Pharm, Takashi Tagawa, B. Pharm, Takako Nozawa ( 10/2011 )